Technology
Unique technology for antibody sequencing and discovery
Griffin
De novo polyclonal antibody sequencing.
Griffin uses mass spectrometry to directly sequence multiple clones present in a polyclonal antibody. The workflow requires only antibody protein, no B cells required.
Polyclonal Antibody Sequencing
Alicanto®
A better way to discover antibodies.
Alicanto® combines next generation sequencing of B cells, mass spectrometry measurements of serum antibodies, and machine learning models to deliver diverse, functional antibodies.
Rabbit Monoclonal Antibody Discovery
Single Domain Antibody Discovery
Human Antibody Discovery
Valens™
Resurrect your monoclonal antibody using proteomic de novo sequencing.
Valens™ uses proprietary technology to sequence monoclonal antibodies when the source cell has been lost. When no source DNA/RNA is available, Valens™ uses proteomics technologies to determine the full-length amino acid sequence of a monoclonal antibody.
Protein Sequence Confirmation
Antibody Protein Sequencing
Reptor™
Antibody repertoire sequencing and analysis.
The adaptive immune response to challenge consists of a dynamic and diverse population of B- and T-lymphocytes. Reptor™ simplifies the interrogation of these populations by combining next-generation sequencing with repertoire analysis.
Next-Generation Sequencing HT Hybridoma
Next-Generation Sequencing Bulk B Cells
Next-Generation Sequencing Hit Expansion
Next-Generation Sequencing Display Library
Get In Touch